Year in Review: HIV
Long-acting therapies headlined a year of continued drug development, both in the treatment and prevention of HIV. Meanwhile, CDC recommended a third dose of a COVID-19 mRNA vaccine for certain patients living with advanced or untreated HIV to boost their protection. Cabotegravir’s Big Year The year started with the approval of cabotegravir-rilpivirine (Cabenuva), the first […]